EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,436 | -15.9% | 5,164 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $96,811 | -39.0% | 4,980 | -11.0% | 0.00% | 0.0% |
| Q1 2023 | $158,787 | -2.5% | 5,597 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $162,899 | +7.9% | 5,573 | -2.2% | 0.00% | 0.0% |
| Q3 2022 | $151,000 | -40.1% | 5,700 | +0.4% | 0.00% | -50.0% |
| Q2 2022 | $252,000 | -22.2% | 5,678 | -13.3% | 0.00% | 0.0% |
| Q1 2022 | $324,000 | -8.5% | 6,546 | -5.8% | 0.00% | 0.0% |
| Q4 2021 | $354,000 | -12.8% | 6,949 | -4.6% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | +25.7% | 7,284 | -3.5% | 0.00% | +100.0% |
| Q2 2021 | $323,000 | +10.2% | 7,548 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $293,000 | -11.5% | 7,015 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $331,000 | +1.8% | 7,104 | -7.0% | 0.00% | -50.0% |
| Q3 2020 | $325,000 | -11.2% | 7,639 | +0.0% | 0.00% | 0.0% |
| Q2 2020 | $366,000 | +24.9% | 7,637 | +20.1% | 0.00% | 0.0% |
| Q1 2020 | $293,000 | -26.9% | 6,360 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $401,000 | +3.4% | 6,672 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $388,000 | -1.5% | 6,862 | -3.0% | 0.00% | 0.0% |
| Q2 2019 | $394,000 | -1.7% | 7,074 | -11.0% | 0.00% | 0.0% |
| Q1 2019 | $401,000 | +20.8% | 7,952 | -3.6% | 0.00% | +100.0% |
| Q4 2018 | $332,000 | -42.8% | 8,250 | -1.4% | 0.00% | -50.0% |
| Q3 2018 | $580,000 | -1.4% | 8,366 | +7.6% | 0.00% | 0.0% |
| Q2 2018 | $588,000 | +117.0% | 7,772 | +51.2% | 0.00% | +100.0% |
| Q1 2018 | $271,000 | -21.2% | 5,139 | -20.1% | 0.00% | 0.0% |
| Q4 2017 | $344,000 | -12.0% | 6,431 | -2.0% | 0.00% | 0.0% |
| Q3 2017 | $391,000 | -18.9% | 6,562 | +7.3% | 0.00% | -50.0% |
| Q2 2017 | $482,000 | +6.6% | 6,116 | +12.2% | 0.00% | 0.0% |
| Q1 2017 | $452,000 | -10.0% | 5,451 | -13.9% | 0.00% | 0.0% |
| Q4 2016 | $502,000 | -99.9% | 6,332 | -1.6% | 0.00% | 0.0% |
| Q3 2016 | $450,520,000 | +127.9% | 6,436 | +26.3% | 0.00% | +100.0% |
| Q2 2016 | $197,713,000 | -13.3% | 5,097 | -9.4% | 0.00% | 0.0% |
| Q1 2016 | $228,000,000 | -54.3% | 5,625 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $499,000,000 | +119564.3% | 5,625 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $417,000 | -99.9% | 5,634 | +12.1% | 0.00% | 0.0% |
| Q2 2015 | $406,564,000 | – | 5,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |